Table 2.
Characteristic | No. (%) |
---|---|
Hospital ward | |
Hematology | 89 (26.7) |
Infectious diseases | 76 (22.8) |
Internal medicine | 53 (15.9) |
Intensive care unit | 48 (14.4) |
Surgery | 19 (5.7) |
Other* | 48 (14.5) |
Antifungal agents | |
Fluconazole | 268 (80.5) |
Lipid amphotericin B | 24 (7.2) |
Echinocandin | 20 (6.0) |
Voriconazole | 11 (3.3) |
Posaconazole | 5 (1.5) |
Deoxycholate amphotericin B | 5 (1.5) |
Indication | |
Targeted treatment | 197 (59.1) |
Empiric | 59 (17.8) |
Prophylaxis | 53 (15.9) |
No apparent reason | 24 (7.2) |
Other ward: nephrology (n=14), gastroenterology (n=8), hepatology (n=8), cardiology (n=5), ward for patients with multi-drug-resistant colonization or infection (n=4), psychiatry (n=4), emergency (n=3), pulmonology (n=2)